Atlas Healthcare Partners | June 29, 2022
An industry first cardiovascular-focused ambulatory surgery center (ASC) business has been formed by Atlas Healthcare Partners and MedAxiom. Atlas Healthcare Partners specializes in creating and operating ambulatory surgery centers (ASCs). By increasing access to top-notch, patient-centered heart care in ASCs, Atlas and MedAxiom will improve cardiovascular care as a whole.
With its health system and physician partners, Atlas, the fastest-growing firm in the ASC sector, has a highly integrated strategy that focuses on coordinating doctors and ASCs with the health system's delivery network and plan.
"We're very excited about the opportunity to partner with MedAxiom. MedAxiom has an excellent national reputation as the cardiovascular performance management leader. Together, we will bring a new level of cardiovascular ASC expertise and experience to health systems and physicians throughout the country."
Aric Burke, Atlas CEO
MedAxiom connects cardiovascular programs, leaders, and industry partners to accomplish the Quadruple Aim of high-quality outcomes, lower costs, improved patient experience, and high physician satisfaction. MedAxiom is the pioneer in cardiovascular operational excellence and performance improvement. Through the integration of technology, innovation, and care delivery, MedAxiom is reshaping the future of cardiovascular care.
"Our ambition to enhance cardiovascular care and improve heart health demands creative tactics and solid relationships. Atlas is a renowned leader and expert in outpatient care with a clear line of vision towards the development of ASC service lines. Health systems and physicians wishing to enter the outpatient treatment market now have a solution thanks to the combination of Atlas' significant ASC experience and MedAxiom's cardiovascular-specific knowledge."
Jerry Blackwell, MD, MBA, FACC, president and CEO of MedAxiom
Greenway Health | July 20, 2022
Greenway Health, a leading health information technology services provider, launched Greenway Medical Coding services, its newest healthcare solution for ambulatory practices. Greenway Medical Coding enables practices to capture cost efficiencies, improve practice earning potential, and collect insurance payments efficiently with the knowledge and precision of a personalized coding team.
Medical coding is the transformation of medical diagnoses, procedures, and services into a universal alphanumeric code. These comprehensive codes are used to submit and process charges in the healthcare billing system. Greenway Medical Coding will provide coding services by a dedicated team of professional coders certified by the American Academy of Professional Coders (AAPC) and/or American Health Information Management Association.
"With 69 percent of healthcare leaders reporting an increase in denials in 2021, Greenway Medical Coding relieves staffing issues and decreases the number of denials so practices can focus on what they do best – taking care of patients. Our new medical coding solution is a way for us to help clients reduce denials, minimize risks, and improve overall patient satisfaction
David Cohen, Chief Product and Technology Officer
Greenway clients will benefit from the multi-specialty expertise of certified medical coders experiencing cleaner claims with faster insurance payments, access to auditing services, and efficient medical coding submissions.
"Greenway is dedicated to providing the right tools for our clients to be successful and improve patient care," said Pratap Sarker, CEO of Greenway Health. "After listening to the struggles providers have had with maintaining coding staff, we knew we needed to provide a solution to relieve their administrative burden and allow for our providers to focus on patients."
Greenway is an end-to-end EHR, practice management, and medical billing solutions provider with a full suite of adaptable technology options including revenue cycle management, telehealth, care coordination services, patient engagement, and much more.
About Greenway Health
Greenway Health provides electronic health records (EHR), practice management, and revenue cycle management solutions that help practices in multiple specialties grow profitably, remain compliant, work more efficiently, and improve patient outcomes. Its team of clinical, financial, and technology experts serve as trusted advisors, committed to enabling successful providers, empowering patients, and building healthier communities. Greenway works with more than 55,000 providers across multiple specialties, translating into millions of lives touched daily by its solutions.
nference | September 22, 2022
nference, a science-first software company transforming healthcare by making biomedical data computable announced the launch of its AI-driven nSights platform, which will allow biopharma, medical device companies, and diagnostic firms to access and directly engage with curated, de-identified healthcare data to advance research and discovery.
The company also expanded its exclusive 12-year strategic relationship with Mayo Clinic, providing nference partners and customers with access to Mayo Clinic Platform’s extensive de-identified electronic health data across a range of disease and therapeutic areas. This expanded collaboration will increase access to data-derived insights and knowledge by establishing a Mayo Clinic-branded version of nSights, called Mayo Clinic Platform_Discover, built and supported by nference to help its partners solve some of the most complex clinical challenges.
nSights is a software platform that makes real-world data available across multiple data modalities (clinical, molecular, and imaging). The platform enables data exploration, hypothesis generation, analytics, and data science capabilities, including algorithm development, for users of all backgrounds. nSights provides a longitudinal, 360-degree view of each patient by leveraging an ensemble of biomedical information, such as electronic health records, electrocardiograms, radiology images and more. Future iterations will also include digital pathology and genomics. The platform is supported by a flexible data dictionary, allowing for the generation of new patient-level features for analysis.
“The potential of electronic health data remains locked at medical centers and is frequently under-leveraged due to data complexity, privacy, and security concerns. Our expanded collaboration with Mayo Clinic Platform provides the framework for nference’s deployment of nSights and enables our customers to access de-identified ‘patient-level’ data to drive research and development of new therapeutics. I look forward to continuing to build and fortify our partnership with the Mayo Clinic team as we work together to improve healthcare through data-derived insights and knowledge.”
Mike Koenig, chief commercial officer at nference
As a result of the company’s partnerships with major academic medical centers like Mayo Clinic, nSights provides access to the deepest curated patient-level dataset available across all therapeutic areas, including cardiology, oncology, metabolic diseases, immunology, and infectious diseases. The platform offers insights from both structured and unstructured records, representing more than 20 years of longitudinality, including data from over 520 million clinical notes, 1.3 billion lab test results, 10.2 billion flowsheets, and more.
“Over the past year, our collaboration with nference, leveraging nSights, has accelerated clinical decision support and care in significant ways," said Maneesh Goyal, chief operating officer, Mayo Clinic Platform. "Data-derived insights and knowledge help us accelerate and enhance innovation and meet the unmet needs of patients everywhere.”
Through its powerful technology platform and software, nference is transforming health care by making biomedical knowledge computable. Its partnership with Mayo Clinic has given nference an opportunity to synthesize decades of institutional knowledge, producing real-world evidence in real-time by converting large amounts of de-identified data into deep insights to advance discovery and development of diagnostics and therapeutics. Its proprietary AI-enabled software platform, nSights, has been used to accelerate life sciences research, development, and clinical care in significant ways, including biomarker discovery and validation, real-world evidence generation leveraging real-world data, early disease detection, public health policy generation and validation, and more. nference is headquartered in Cambridge, Mass.